Business Context and Reporting Period
This Form 8-K was filed by Griffin-American Healthcare REIT IV, Inc. on September 13, 2018. The registrant is an emerging growth company. The report details a material definitive agreement regarding the potential acquisition of the Songbird SNF Portfolio.
Key Financial Metrics and Transaction Details
- Transaction Type: Purchase and sale agreement for real property and related interests.
- Contract Purchase Price: $78,500,000, plus closing costs.
- Asset Scope: 24 healthcare facilities (21 skilled nursing facilities, 1 assisted living facility in Illinois; 2 skilled nursing facilities in Missouri).
- Physical Metrics: Approximately 625,000 square feet of gross leasable area and 2,104 licensed beds.
- Leasing Status: 100% leased at the time of acquisition.
- Counterparties: Sellers include Midwest Health Properties, LLC and various Petersen Health Care entities; Tenant is POP, LLC; Guarantor is Mark B. Petersen.
The filing text does not provide clear values for the company's current revenue, profit, cash flow, margins, debt, or liquidity metrics, as this report focuses solely on the specific transaction.
Material Changes and Recent Developments
On September 13, 2018, the registrant entered into a Second Amendment to the previously disclosed Purchase Agreement (originally filed July 30, 2018, and amended September 7, 2018). The material change effected by this amendment is the extension of the due diligence period to September 21, 2018.
Outlook, Risks, and Management Commentary
- Closing Timeline: Management anticipates closing the acquisition in the fourth quarter of 2018.
- Uncertainty: The registrant provides no assurance that the closing will occur within the anticipated timeframe or at all.
- Conditions: The acquisition is subject to substantial conditions to closing.
- Risks: Failure to satisfy closing conditions could result in the transaction not being completed.
Key Facts for Investor Verification
- Verify the status of the due diligence period which was extended to September 21, 2018.
- Confirm whether the substantial conditions to closing have been satisfied to enable the anticipated Q4 2018 closing.
- Review the specific closing costs associated with the $78.5 million purchase price.
- Monitor subsequent filings for confirmation of the transaction's completion or termination.